NASDAQ:ELDN | Insider Transactions — Page 2 | Eledon Pharmaceuticals, Inc.

ELDN Insider Transactions — Page 2

130 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 101–130; provenance stays internal.

Insider profileRoleDateTransactionSharesPrice
NOVARTIS AGTenPercentOwner2015-07-15Sale3,566.0$14.26
Novartis Bioventures LtdTenPercentOwner2015-07-15Sale3,566.0$14.26
NOVARTIS AGTenPercentOwner2015-07-14Sale27,861.0$14.41
Novartis Bioventures LtdTenPercentOwner2015-07-14Sale27,861.0$14.41
NOVARTIS AGTenPercentOwner2015-07-13Sale20,611.0$14.2
Novartis Bioventures LtdTenPercentOwner2015-07-13Sale20,611.0$14.2
Morrison Jodie PopePresident and CEO2015-06-29Sale8,000.0$13.7
Morrison Jodie PopePresident and CEO2015-06-26Sale8,000.0$13.83
McBride John S.Chief Operating Officer2015-06-24Sale300.0$14.2
McBride John S.Chief Operating Officer2015-06-23Sale6,700.0$14.0
McBride John S.Chief Operating Officer2015-06-22Sale2,000.0$14.02
NOVARTIS AGTenPercentOwner2015-06-16Sale1,120.0$14.27
Novartis Bioventures LtdTenPercentOwner2015-06-16Sale1,120.0$14.27
NOVARTIS AGTenPercentOwner2015-06-12Sale5,919.0$14.2
Novartis Bioventures LtdTenPercentOwner2015-06-12Sale5,919.0$14.2
NOVARTIS AGTenPercentOwner2015-06-11Sale27,875.0$14.2
Novartis Bioventures LtdTenPercentOwner2015-06-11Sale27,875.0$14.2
Kalowski LeeChief Financial Officer2015-04-16Sale4,567.0$13.0
Kalowski LeeChief Financial Officer2015-04-02Sale2,258.0$11.45
NOVARTIS AGTenPercentOwner2015-03-19Sale46,141.0$14.5
Novartis Bioventures LtdTenPercentOwner2015-03-19Sale46,141.0$14.5
NOVARTIS AGTenPercentOwner2015-03-18Sale3,000.0$14.5
Novartis Bioventures LtdTenPercentOwner2015-03-18Sale3,000.0$14.5
Satter Muneer ATenPercentOwner2014-09-22Purchase150,000.0$15.0
Apple Tree Partners II - Annex, L.P.Director,TenPercentOwner2014-09-22Purchase237,500.0$15.0
Harrison Seth LoringDirector,TenPercentOwner2014-09-22Purchase362,500.0$15.0
NOVARTIS AGTenPercentOwner2014-09-22Purchase325,000.0$15.0
Novartis Bioventures LtdTenPercentOwner2014-09-22Purchase325,000.0$15.0
NOVARTIS AGTenPercentOwner2014-06-15Sale14,777.0$14.2
Novartis Bioventures LtdTenPercentOwner2014-06-15Sale14,777.0$14.2